» Articles » PMID: 25284592

Managing Fetuses at High Risk of Retinoblastoma: Lesion Detection on Screening MRI

Overview
Journal Prenat Diagn
Publisher Wiley
Date 2014 Oct 7
PMID 25284592
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to describe tumour identification on magnetic resonance imaging (MRI) in a 35-week fetus with familial retinoblastoma (RB) and report the use of prenatal ultrasound (US) and MRI screening in the management of fetuses at high risk of RB.

Method: This is a retrospective review of the prenatal course and immediate postnatal findings in all children considered at high risk of RB who had prenatal imaging with both US and MRI at our institution over a 5-year period.

Results: Five patients met the inclusion criteria. No lesions were identified on US in any patients. Fetal MRI identified bilateral posterior pole lesions in one patient at 35 weeks' gestation. Of the four remaining patients, three developed lesions by 5 weeks of age. Only one fetus was delivered early following detection of RB.

Conclusion: We present the first reported case of RB detected in a high-risk fetus on screening MRI at 35 weeks' gestation. A protocol for screening this population using both imaging modalities is presented.

Citing Articles

Prenatal Diagnosis of Retinoblastomas: A Scoping Review.

Rodriguez A, Kelley C, Patel A, Ramasubramanian A Int J Gen Med. 2023; 16:1101-1110.

PMID: 37007908 PMC: 10064871. DOI: 10.2147/IJGM.S380634.


At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review.

van Hoefen Wijsard M, Serne S, Otten R, Bosscha M, Dommering C, Fabius A Cancers (Basel). 2021; 13(8).

PMID: 33920538 PMC: 8072927. DOI: 10.3390/cancers13081942.


Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges.

Neupane R, Gaudana R, Boddu S AAPS J. 2018; 20(6):97.

PMID: 30187172 DOI: 10.1208/s12248-018-0259-9.


Prenatal ultrasonographic detection and prenatal (prior to birth) management of hereditary retinoblastoma.

Stathopoulos C, Say E, Shields C Graefes Arch Clin Exp Ophthalmol. 2017; 256(4):861-862.

PMID: 29151167 DOI: 10.1007/s00417-017-3841-4.


Neonatal Retinoblastoma.

Kivela T, Hadjistilianou T Asia Pac J Oncol Nurs. 2017; 4(3):197-204.

PMID: 28695165 PMC: 5473090. DOI: 10.4103/apjon.apjon_18_17.